Adiponectin Testing Market Size & Share, by Type (ELISA, Enzyme Immunoassay); Product (Assay, Software & Services); End-user (Hospitals, Diagnostic Laboratories, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4140
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Adiponectin Testing Landscape

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Laboratory Corporation of America Holdings
    • Bio-Rad Laboratories, Inc.
    • Boster Biological Technology
    • Thermo Fisher Scientific Inc.
    • Eagle Biosciences, Inc.
    • Merck KGaA
    • ERBA Diagnostics, Inc.
    • Zeus Scientific Inc.
    • Trinity Biotech plc

Browse Key Market Insights with Data Illustration:


In The News

  • Laboratory Corporation steps ahead to develop efficient clinical trial processes via Clinical Trial Management System (CTMS) which is referred to as a central repository.

    Bio-Rad to merge its path with ADInstruments for the integration of the Bio-Rad Explorer Classroom Activities with Lt Biology, a newly updated collection of ADInstruments.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4140
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing adoption of adipose-derived products and the higher prevalence of cardio-metabolic diseases globally are the major factors driving the growth of the adiponectin testing market.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2035.

Lack of requisite for enhanced technology and requirement for higher initial investment is estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are STRATEC SE, Laboratory Corporation of America Holdings, Bio-Rad Laboratories, Inc., Boster Biological Technology, Merck KGaA, ERBA Diagnostics, Inc., Zeus Scientific Inc., and Trinity Biotech plc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, product, end user, and by region.

The ELISA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying